Skip to content

Neurona Therapeutics Presents Positive Clinical Update from NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2024 Annual Meeting

NRTX-1001 administration has been well-tolerated in all individuals treated to date

Neurona Therapeutics Presents Positive Clinical Update from NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2024 Annual Meeting
Author Avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
View Full Bio
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu

Similar Posts

Logo for LabNewsAI Exklusiv featuring a stylized microscope and molecular network with blueteal typography and the tagline INNOVATION TECHNOLOGY KNOWLEDGE

Frozen Conflict Ukraine: Implications for Medicine, Biotech, and Research

A “frozen conflict” is not yet a reality, but the medical and life science systems of Ukraine and Russia have been permanently reshaped by the war. Currently (late… 

more »Frozen Conflict Ukraine: Consequences for Medicine, Biotech, and Research
Laboratory setup with a glowing neon DNA helix and optical equipment on a bench monitors showing graphs in the background and researchers at work

Yeast genome shuffling creates new poxviruses for cancer therapy

Researchers at the French biotech company Transgene have developed a method for creating chimeric viruses with potentially oncolytic properties from several poxviruses. As the…

more »Yeast genome shuffling creates new poxviruses for cancer therapy

Review: Bioengineering Technologies for Biomedicine in Space

Tissue engineering, 3D bioprinting, tissue chips, and biosensors could advance biomedical research in space. This is the conclusion of a review article by researchers at Cedars-Sinai Medical Center… 

more »Review: Bioengineering Technologies for Biomedicine in Space